tradingkey.logo
tradingkey.logo

Sensus Healthcare Inc

SRTS
3.870USD
-0.050-1.28%
Close 03/30, 16:00ETQuotes delayed by 15 min
48.14MMarket Cap
LossP/E TTM

Sensus Healthcare Inc

3.870
-0.050-1.28%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Sensus Healthcare Inc

Currency: USD Updated: 2026-03-30

Key Insights

Sensus Healthcare Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 92 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.88.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sensus Healthcare Inc's Score

Industry at a Glance

Industry Ranking
92 / 208
Overall Ranking
222 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Sensus Healthcare Inc Highlights

StrengthsRisks
Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Growing
The company is in a growing phase, with the latest annual income totaling USD 27.48M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -8.19, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.96M shares, decreasing 25.49% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 257.03K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.03.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
6.875
Target Price
+75.38%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-30

The current financial score of Sensus Healthcare Inc is 6.62, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 4.94M, representing a year-over-year decrease of 62.20%, while its net profit experienced a year-over-year decrease of 304.85%.

Score

Industry at a Glance

Previous score
6.62
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.05

Operational Efficiency

4.86

Growth Potential

4.08

Shareholder Returns

7.11

Sensus Healthcare Inc's Company Valuation

Currency: USD Updated: 2026-03-30

The current valuation score of Sensus Healthcare Inc is 8.90, ranking 2 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -8.19, which is -2110.84% below the recent high of 164.60 and -1228.40% above the recent low of -108.74.

Score

Industry at a Glance

Previous score
8.90
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 92/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-30

The current earnings forecast score of Sensus Healthcare Inc is 8.00, ranking 62 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 8.00, with a high of 8.00 and a low of 6.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
6.875
Target Price
+75.38%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

92
Total
4
Median
7
Average
Company name
Ratings
Analysts
Sensus Healthcare Inc
SRTS
4
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-30

The current price momentum score of Sensus Healthcare Inc is 6.29, ranking 139 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.50 and the support level at 3.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.76
Change
-0.47

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.013
Neutral
RSI(14)
42.945
Neutral
STOCH(KDJ)(9,3,3)
27.683
Sell
ATR(14)
0.220
High Vlolatility
CCI(14)
-79.065
Neutral
Williams %R
81.356
Oversold
TRIX(12,20)
-0.369
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
3.996
Sell
MA10
3.970
Sell
MA20
4.089
Sell
MA50
4.408
Sell
MA100
4.251
Sell
MA200
4.063
Sell

Institutional Confidence

Currency: USD Updated: 2026-03-30

The current institutional shareholding score of Sensus Healthcare Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 30.17%, representing a quarter-over-quarter increase of 4.98%. The largest institutional shareholder is The Vanguard, holding a total of 728.92K shares, representing 4.43% of shares outstanding, with 1.60% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Solot (Edwin L)
1.25M
-18.78%
Sardano (Joseph C)
1.20M
+2.13%
The Vanguard Group, Inc.
Star Investors
728.92K
-1.50%
Pacific Ridge Capital Partners, LLC
573.39K
+26.09%
Dimensional Fund Advisors, L.P.
569.31K
-5.51%
Florida State Board of Administration
264.78K
+39.60%
Driehaus Capital Management, LLC
288.73K
+22.26%
Divisadero Street Capital Management, LP
452.90K
+39.49%
Renaissance Technologies LLC
Star Investors
261.13K
+4.40%
Geode Capital Management, L.L.C.
152.92K
-0.65%
1
2

Risk Assessment

Currency: USD Updated: 2026-03-30

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sensus Healthcare Inc is 3.04, ranking 132 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.29. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
3.04
Change
0
Beta vs S&P 500 index
1.29
VaR
+5.67%
240-Day Maximum Drawdown
+45.31%
240-Day Volatility
+85.05%

Return

Best Daily Return
60 days
+14.97%
120 days
+19.32%
5 years
+38.85%
Worst Daily Return
60 days
-16.99%
120 days
-16.99%
5 years
-51.23%
Sharpe Ratio
60 days
+0.62
120 days
+0.70
5 years
+0.42

Risk Assessment

Maximum Drawdown
240 days
+45.31%
3 years
+65.63%
5 years
+87.51%
Return-to-Drawdown Ratio
240 days
-0.42
3 years
+0.17
5 years
-0.03
Skewness
240 days
-1.14
3 years
+0.31
5 years
-1.10

Volatility

Realised Volatility
240 days
+85.05%
5 years
+89.15%
Standardised True Range
240 days
+6.60%
5 years
+10.23%
Downside Risk-Adjusted Return
120 days
+130.34%
240 days
+130.34%
Maximum Daily Upside Volatility
60 days
+78.25%
Maximum Daily Downside Volatility
60 days
+55.17%

Liquidity

Average Turnover Rate
60 days
+0.79%
120 days
+0.71%
5 years
--
Turnover Deviation
20 days
-3.46%
60 days
-39.49%
120 days
-46.03%

Peer Comparison

Healthcare Equipment & Supplies
Sensus Healthcare Inc
Sensus Healthcare Inc
SRTS
6.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.04 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
Boston Scientific Corp
BSX
7.95 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI